Published in J Clin Oncol on February 01, 1985
Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. Br J Cancer (2004) 0.87
Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer. Br J Cancer (1991) 0.86
32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications. Environ Health Perspect (1987) 0.84
A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats. Br J Cancer (1990) 0.82
Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans. G3 (Bethesda) (2015) 0.77
A Management Algorithm for Mitomycin C Induced Cystitis. Bladder Cancer (2017) 0.75
Characterization of a BMS-181174-resistant human bladder cancer cell line. Br J Cancer (1997) 0.75
Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer (2010) 0.75
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Ribosome gymnastics--degree of difficulty 9.5, style 10.0. Cell (1990) 4.01
Recoding: reprogrammed genetic decoding. Science (1992) 2.92
Genomic sequence of hyperthermophile, Pyrococcus furiosus: implications for physiology and enzymology. Methods Enzymol (2001) 2.67
Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I. Nucleic Acids Res (1995) 2.46
Participatory research in a Native Hawaiian community. The Wai'anae Cancer Research Project. Cancer (1996) 2.27
No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 2.11
Genetic screen for cloned release factor genes. J Bacteriol (1984) 2.09
Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev (2006) 2.03
Divergence of the hyperthermophilic archaea Pyrococcus furiosus and P. horikoshii inferred from complete genomic sequences. Genetics (1999) 1.94
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med (1986) 1.90
Only one of two closely related yeast suppressor tRNA genes contains an intervening sequence. Nature (1981) 1.87
Transcriptional slippage occurs during elongation at runs of adenine or thymine in Escherichia coli. Nucleic Acids Res (1990) 1.87
Impact of a culturally appropriate intervention on breast and cervical screening among native Hawaiian women. Prev Med (2000) 1.71
Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study. J Clin Oncol (1991) 1.65
Cytarabine and neurologic toxicity. J Clin Oncol (1991) 1.64
Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu Rev Genet (1991) 1.62
Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev (1979) 1.60
Duplications in the DMD gene. Hum Mutat (2006) 1.58
Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev (1995) 1.55
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A (2005) 1.54
A breast and cervical cancer project in a native Hawaiian community: Wai'anae cancer research project. Prev Med (1995) 1.52
Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol (1996) 1.49
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1991) 1.47
Testicular lymphoma. Semin Oncol (1999) 1.45
Suramin-induced skin reactions. Arch Dermatol (1992) 1.45
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B. Cancer (1992) 1.44
Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Ann Oncol (1995) 1.42
Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics (1990) 1.40
Hypertensive reactions associated with paclitaxel. Cancer Invest (1996) 1.38
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36
Evidence of recent lateral gene transfer among hyperthermophilic archaea. Mol Microbiol (2000) 1.31
Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet (2005) 1.31
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30
Vascular toxicity associated with antineoplastic agents. J Clin Oncol (1986) 1.27
Streptozocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep (1982) 1.26
Small-cell carcinoma of the lung: therapeutic management. Ann Intern Med (1978) 1.25
Clinical pharmacology of mezlocillin. Antimicrob Agents Chemother (1978) 1.21
Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 1.21
Anthracycline analogs: the past, present, and future. Cancer Chemother Pharmacol (1986) 1.19
The value of the physical examination in the diagnosis of anemia. Correlation of the physical findings and the hemoglobin concentration. Arch Intern Med (1988) 1.18
Cytotoxic drug-induced pulmonary disease: update 1980. Am J Med (1980) 1.18
Molecular model of ribosome frameshifting. Proc Natl Acad Sci U S A (1984) 1.13
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst (1993) 1.12
An efficient Shine-Dalgarno sequence but not translation is necessary for lacZ mRNA stability in Escherichia coli. J Bacteriol (1994) 1.12
Enzyme-linked fluorescent detection for automated multiplex DNA sequencing. Genomics (1994) 1.09
Malignant lymphoma of the testis. Am J Med (1986) 1.08
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Cerebral thrombosis in smokers' polycythemia. Ann Intern Med (1985) 1.06
Coral reefs, forests, and thermal vents: the worldwide exploration of nature for novel antitumor agents. Semin Oncol (1997) 1.05
Frameshift suppression in aminoacyl-tRNA limited cells. Genetics (1986) 1.05
Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep (1981) 1.04
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol (1998) 1.04
Mutants of translational components that alter reading frame by two steps forward or one step back. J Biol Chem (1988) 1.04
DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet (2002) 1.03
Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Ann Intern Med (1989) 1.03
Functional hyposplenism. South Med J (1987) 1.02
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood (1991) 1.02
cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics (1991) 1.02
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemother Pharmacol (1995) 1.02
Transposition of mercury resistance from a transferable R plasmic of Escherichia coli. Plasmid (1980) 1.02
Clinical pharmacology of intraperitoneal cisplatin. Gynecol Oncol (1985) 1.02
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study. Am J Clin Oncol (1984) 1.02
Squamous cell carcinoma of the pancreas associated with hypercalcemia. Gastroenterology (1982) 1.01
A mutation in ribosomal protein L9 affects ribosomal hopping during translation of gene 60 from bacteriophage T4. Proc Natl Acad Sci U S A (1994) 0.99
Developmental vulnerabilities to the onset and course of bipolar disorder. Dev Psychopathol (2001) 0.98
Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer (1996) 0.97
Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension (1997) 0.96
Photoalkylated DNA and ultraviolet-irradiated DNA are incised at cytosines by endonuclease III. Nucleic Acids Res (1986) 0.96
Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer (1989) 0.96
Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphocytic leukemia and blast expression of the neural cell adhesion molecule. Am J Hematol (1997) 0.95
The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol (1988) 0.95
Lymphoma and pregnancy. Semin Oncol (1989) 0.95
Antibacterial prophylaxis: ideas old and new. W V Med J (1977) 0.94
Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med (1981) 0.94
Etoposide (VP-16-213). Cancer Treat Rev (1979) 0.93
Enhancement of natural killer activity in human peripheral blood by flavone acetic acid. J Natl Cancer Inst (1988) 0.93
The use of modified primers to eliminate cycle sequencing artifacts. Nucleic Acids Res (1999) 0.93
Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration. Am J Med (1991) 0.93
Evans' syndrome associated with microcystic adenoma of the pancreas. Cancer (1987) 0.92
Tumors of unknown origin in the bone marrow. Arch Intern Med (1986) 0.91
Amsacrine-associated cardiotoxicity: an analysis of 82 cases. J Clin Oncol (1986) 0.91
Burkitt's lymphoma in a homosexual. Lancet (1982) 0.91
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240). Cancer Res (1983) 0.91
Prospects for immunotoxin therapy in cancer. Annu Rev Med (1986) 0.91
Treatment of small cell undifferentiated carcinoma of the lung: update of recent results. Cancer Treat Rep (1981) 0.89
The nitrosoureas and pulmonary toxicity. Cancer Treat Rev (1981) 0.89
Maytansine. Cancer Treat Rev (1978) 0.89
Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer (1988) 0.89
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study. Recent Results Cancer Res (1982) 0.89
Heterologous in vitro fertilization and sperm capacitation in an endangered African antelope, the scimitar-horned oryx (Oryx dammah). Biol Reprod (1998) 0.88
Enzymic detection of uracil in a cloned and sequenced deoxyribonucleic acid segment. Biochemistry (1983) 0.88
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. J Clin Oncol (1983) 0.88
Tattooing in prison and HIV infection. Lancet (1988) 0.87